Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Pallavi Mukherjee to Help Travel and Food Industry through Popdiaries Lifestyle
  • SMEBIZZ Celebrated WORLD MSME DAY Business
  • DhaSh PV Technologies Limited Announces Rs 346.35 Crore Mega Solar PV Manufacturing Plant at Sira, Tumkur Business
  • On This Doctors Day: Gynaecologist’s Advice on PCOS, Menopause & Screening in Pregnancy Health
  • Conspiracy to change the name of the film Bikroo Kanpur gangster to Encounter Dubey, Conference held to address the fraud convicted Entertainment
  • Luxury Time Limited IPO To Open On 04th December, Sets Price Band at Rs 78 to Rs 82 Per Share Business
  • Prominent Political, Cinema, Social Welfare and Industrial Personalities Honoured In Champion of Change Award Maharashtra 2021 Press Release
  • EV Ultimo launches platform to assist brands, buyers & stakeholders in the Electric Vehicles ecosystem Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Smile In Hour celebrates 2 years of success with over 10,000 happy customers of OSMF Mouth Opening kits Health
  • Breach Candy Hospital Introduces State-of-the-Art Modular Operation Theatres in Collab with Dräger India Health
  • Dr. Vikash Kumar: Noida’s Premier Dentist Setting New Benchmarks in Ethical and Painless Dental Care Health
  • Nagpur Sets Milestone with First-Ever Triple Non-Surgical Heart Valve Replacements in a Single Day Health
  • When the heart failed but hope didn’t Health
  • Unlock Radiant Skin with Ozone Ayurvedics’ Latest Breakthrough: Vitamin C Serum! Health

Recent Posts

  • Why NRIs Are Choosing Svadha Mackenna’s in Kollur for Long-Term Property Investment
  • Why ASG Eye Hospital Is Attracting Attention in India’s Eye Care Sector
  • AIR Commons 2026 Positions Clean Air as a Shared Civic Responsibility, Calls for Ground-Up Action
  • ABS Marine Services Acquire Offshore Support/Supply Vessel (MPSV); The Vessel to Fleet in Q1 FY27
  • SMM Panel Behind Today’s Viral Content Boom

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Switch2Sports: Revolutionizing India’s Sports Industry   Business
  • Celebrating the Commencement of 32 Years of Service: Prime Cooperative Bank Ltd. Marks Foundation Day Business
  • Om Power Transmission Limited Received Approval From SEBI Business
  • Ratnalaya Jewellers Emerges Victorious Again: Earns Big Impact Award 2023 for Exceptional Retail Experience in the Jewellery Sector Business
  • Affordable Marketing: 10 Key Benefits of Indian SMM Panels Business
  • Furniture Lelo Unveils High-Grade Modular Furniture Solutions for Corporates and Residential Business
  • Restore Energy Levels Quickly with The Moon Store’s New Range of Sugar-free Hydration Powder Business
  • A Legendary Offering: Ustad Amjad Ali Khan Unveils Never-Before-Heard Ragas in Inimitable Entertainment

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme